FDA Investigator Dino A Fiegelstock
Dino A Fiegelstock has conducted inspections on 4 sites in 3 countries as of 21 Mar 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
4
Last Inspection Date:
21 Mar 2024
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
Belgium,
United States of America,
United Kingdom of Great Britain and Northern Ireland
FDA Investigators that have inspected at least one site in common with Dino A Fiegelstock:
Anissa M Cheung,
Anita R Michael,
Ann Marie Montemurro,
Brentley S Collins,
Burnell M Henry,
CDR Donald Ertel,
Christian D Lynch (CDL),
Craig D Zagata,
Cynthia Jim, CSO,
Destry M Sillivan,
Dr. Gang Wang, PhD,
Dr. Willie F Vann, PhD,
Dr. Zhihao Qiu (Peter), PhD,
Edmund F Mrak, Jr,
Eileen A Liu,
Eliezar Ramos,
Gene D Arcy,
Haruhiko Murata,
Helen B Ricalde,
Jacqueline Mdiaz Albertini,
James C Maclaughlin,
James E Keller, PhD,
James M Mason,
James R Evans,
Jennifer L Schmidt,
Joan A Loreng,
John M Mcinnis,
Jonathan Mclnnis,
Joseph George,
Joyce A Rockwell,
Julie D Bringger,
Justin A Boyd,
Kirsten L Vadheim, PhD,
Laurie P Norwood,
LCDR Debra Emerson,
Leslie D Wagner,
Marion Michaelis,
Michele L Forster, PhD,
Mihaly S Ligmond,
Nicole K Trudel,
Nikisha M Bolden,
Omotunde O Osunsanmi,
Pankaj H Amin,
Paula A Trost,
Pote Amin,
Prabhu P Raju,
Priscilla M Pastrana,
Rebecca K Olin,
Richard W Thornton,
Robert Sausville,
Robin Levis, PhD,
Roger F Zabinski,
Rose Ashley,
Sarah B Tanksley,
Shuang Tang,
Sidney B Priesmeyer,
Solomon Yimam (SY),
Susan M Jackson,
Swati Verma,
Tina S Roecklein,
Wei Wang, PhD
Dino A Fiegelstock's Documents
Publish Date | Document Type | Title |
---|---|---|
June, 2008 | FDA 483 Response | GlaxoSmithKline Biologicals SA - Form 483R, 2008-06-25 |
June, 2008 | FDA 483 | GlaxoSmithKline Biologicals SA - Form 483, 2008-06-25 |
December, 2007 | FDA 483 | GlaxoSmithKline Biologicals SA - Form 483, 2007-12-13 |
April, 2018 | EIR | Valneva Scotland Ltd. - EIR, 2018-04-24 |
October, 2018 | FDA 483 | Sanofi Pasteur Inc. - Form 483, 2018-10-26 |
June, 2008 | EIR | GlaxoSmithKline Biologicals SA - EIR, 2008-06-25 |
December, 2007 | FDA 483 Response | GlaxoSmithKline Biologicals SA - Form 483R, 2008-01-17 |
December, 2007 | EIR | GlaxoSmithKline Biologicals SA - EIR, 2008-03-25 |
October, 2018 | EIR | Sanofi Pasteur Inc. - EIR, 2018-12-21 |
April, 2018 | FDA 483 | Valneva Scotland Ltd. - Form 483, 2018-04-24 |
October, 2018 | FDA 483 Response | Sanofi Pasteur Inc. - Form 483R, 2018-11-15 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more